Gingival hyperplasia related to treatment with diphenylhydantoin (diphedan; DH).
D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone / Q000502:physiology; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D005885:Gingival Hyperplasia / Q000139:chemically induced*; D005938:Glucocorticoids / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects*; D010913:Pituitary-Adrenal System / Q000187:drug effects
D015068:17-Ketosteroids; D005938:Glucocorticoids; D010672:Phenytoin; D000324:Adrenocorticotropic Hormone